This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.
: Lexaria Bioscience Started At Buy With $2 Stock Price Target At Maxim Group
MarketWatch.com - Real-time Headlines, MarketWatch: Real-time Headlines
Fri, 07/21/2023 - 4:55am
BING NEWS:
- Lexaria Bioscience holds buy rating, steady stock target on positive study results
On Monday, H.C. Wainwright maintained a Buy rating on Lexaria Bioscience (NASDAQ ... development and the firm's continued endorsement of Lexaria Bioscience's stock with a $10 price target reflects ...
11/24/2024 - 11:24 pm | View Link - Lexaria Bioscience holds buy rating, steady stock target on positive study results
On Monday, H.C. Wainwright maintained a Buy rating on Lexaria Bioscience ... firm's continued endorsement of Lexaria Bioscience's stock with a $10 price target reflects optimism in the company's ...
11/24/2024 - 6:21 pm | View Link - Maxim Group Issues Buy Rating for MicroStrategy Inc (MSTR) Stock
Maxim Group has recently reiterated MicroStrategy Inc (MSTR) stock to Buy rating, as announced on October 31, 2024, according to Finviz. Earlier, on September 6, 2024, Barclays had initiated the stock ...
11/15/2024 - 3:59 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more